First North announcement # 1, 2008 / January 28, 2008 Copenhagen, January 28, 2008 Aresa A/S has entered into new agreements regarding continued use of test sites in Croatia and Serbia. Aresa A/S has entered into new agreements with their cooperation partners in Croatia and Serbia regarding use of the two test sites, which were established in 2007. The agreement with the National Center for Training and Accreditation of Mine Action (HCR-CTRO) in Croatia has been renewed for 2008. The center is important for the activities of Aresa: using land mines in various tests, including soil sampling; mechanical mine clearing tests; and experimental seeding of tobacco in mine fields. In Serbia, the agreement with the leading plant breeding institute within tobacco plants has been prolonged by another year. The agreement gives Aresa the opportunity to start seeding newly developed tobacco plants in the open in soil spiked with different concentrations of explosives during the growth season of 2008. The experiment will enable Aresa to select the proper plants for the future commercialization of RedDetect®. For more information, please contact Steen Thaarup CEO Phone: +45 7022 7747 Mobile: +45 4077 8695 E-mail: st@aresa.dk The company's financial advisor is Dahl-Sørensen & Partners A/S, Allan Reimann, tel.: +45 3364 9205. About Aresa Aresa is a plant biotech company established in 2001 by the company's current CSO, Carsten Meier. Its origins come from the Institute of Molecular Biology at Copenhagen University. Aresa focuses on the plant-based technology platform: BioSensor for the detection of substances in soil, including leakage of explosives from landmines. Aresa was listed on the Copenhagen OMX-First North market place in 2006. Aresa is based at Symbion Science Park in Copenhagen and has greenhouse facilities on the outskirts of Copenhagen and test areas in Denmark, Croatia, and Serbia. Aresa has 11 employees, 7 in research & development and 2 in landmine operations.
Aresa A/S has entered into new agreements regarding continued use of test sites in Croatia and Serbia.
| Source: Aqualife A/S